KAYLA MURRAY: Open Payments
NPI 1164088001 · SLIPPERY ROCK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 5 payments from 4 companies in 2025. Trend: 2023 $875 · 2024 $1,137 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $249 |
| Novo Nordisk Inc | 1 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $14 |
Products named: NUCALA, Ozempic, JASCAYD, QULIPTA.
Industry payments across PA — which companies pay providers there.
